D. Dewailly

发表

Screening for 21-hydroxylase-deficient nonclassic adrenal hyperplasia among hyperandrogenic women: a prospective study.

R. Azziz, L. A. Hincapié, E. Knochenhauer, 1999, Fertility and sterility.

Interactions between androgens, FSH, anti-Müllerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary.

D. Dewailly, C. Decanter, M. Peigné, 2016, Human reproduction update.

Novel role for anti-Müllerian hormone in the regulation of GnRH neuron excitability and hormone secretion

A. Messina, V. Prévot, M. Baroncini, 2016, Nature Communications.

Falsely elevated serum antimüllerian hormone level in a context of heterophilic interference.

D. Dewailly, S. Catteau-jonard, P. Pigny, 2013, Fertility and sterility.

Counting ovarian antral follicles by ultrasound: a practical guide

Stefano Guerriero, Thierry Van den Bosch, George Condous, 2018, Ultrasound in Obstetrics and Gynecology.

[Oncofertility: a new focus in women health-care...].

D. Dewailly, N. Chevalier, P. Fénichel, 2009, Annales d'endocrinologie.

Nuclear estradiol-binding sites in human breast cancer.

J. Bonneterre, B. Hecquet, D. Dewailly, 1983, Cancer research.

Corrigendum to The physiology and clinical utility of anti-Müllerian hormone in women [Hum Reprod Update, 20 (2014) 370-385]

Richard A. Anderson, R. Fanchin, H. Mason, 2014 .

The physiology and clinical utility of anti-Mullerian hormone in women.

Richard A. Anderson, R. Fanchin, H. Mason, 2014, Human reproduction update.

A predictive score for testicular sperm extraction quality and surgical ICSI outcome in non-obstructive azoospermia: a retrospective study.

D. Dewailly, J. Rigot, V. Mitchell, 2011, Human reproduction.

What Is the Appropriate Imaging of the Polycystic Ovary

D. Dewailly, Y. Robert, S. Jonard, 2008 .

Imaging Studies in Polycystic Ovary Syndrome

D. Dewailly, Y. Robert, S. Jonard, 2007 .

Ovarian Histology, Morphology, and Ultrasonography in the Polycystic Ovary Syndrome

D. Dewailly, Y. Robert, S. Jonard, 2006 .

Decreased expression of the two D2 dopamine receptor isoforms in bromocriptine-resistant prolactinomas.

R. Benarous, E. Rouer, F. Féron, 1994, Neuroendocrinology.

Adrenocorticotropin and cortisol responses to ovine corticotropin-releasing factor in alcohol dependence disorder. Preliminary report.

P. Fossati, R. Beuscart, D. Dewailly, 1989, Hormone research.

PCOS and Hyperprolactinemia: what do we know in 2019?

Jacques Young, D. Dewailly, G. Robin, 2019, Clinical medicine insights. Reproductive health.

Diagnostic criteria for PCOS: Is there a need for a rethink?

D. Dewailly, 2016, Best practice & research. Clinical obstetrics & gynaecology.

European survey of diagnosis and management of the polycystic ovary syndrome: results of the ESE PCOS Special Interest Group's Questionnaire.

F. Keleştimur, D. Pignatelli, H. Escobar-Morreale, 2014, European journal of endocrinology.

Polycystic Ovary Syndrome (PCOS)

D. Dewailly, S. Hiéronimus, J. hugues, 2010 .

ANDROGEN EXCESS SOCIETY GUIDELINE SYNDROME AS A PREDOMINANTLY HYPERANDROGENIC SYNDROME: AN POSITION STATEMENT: CRITERIA FOR DEFINING POLYCYSTIC OVARY

R. Norman, H. Escobar-Morreale, E. Diamanti-Kandarakis, 2006 .

8 Definition and significance of polycystic ovaries

D. Dewailly, 1997 .

Interrelationship between Ultrasonography and Biology in the Diagnosis of Polycystic Ovarian Syndrome

P. Fossati, L. Lemaitre, R. Beuscart, 1993, Annals of the New York Academy of Sciences.

Is polycystic ovarian morphology related to a poor oocyte quality after controlled ovarian hyperstimulation for intracytoplasmic sperm injection? Results from a prospective, comparative study.

D. Dewailly, C. Decanter, V. Mitchell, 2015, Fertility and sterility.

First intention IVF protocol for polycystic ovaries: does oral contraceptive pill pretreatment influence COH outcome?

D. Dewailly, M. Leroy, C. Decanter, 2013, Reproductive Biology and Endocrinology.

[Polycystic ovary syndrome: what are the obstetrical risks?].

D. Subtil, D. Dewailly, C. Decanter, 2014, Gynecologie, obstetrique & fertilite.

Long term complications of polycystic ovary syndrome ( PCOS ) Complications à long terme du syndrome des ovaires polykystiques ( SOPK )

D. Dewailly, M. Peigné, 2014 .

Long term complications of polycystic ovary syndrome (PCOS).

D. Dewailly, M. Peigné, 2014, Annales d'endocrinologie.

Oligoanovulation with polycystic ovaries but not overt hyperandrogenism.

D. Dewailly, M. Leroy, S. Catteau-jonard, 2006, The Journal of clinical endocrinology and metabolism.

Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome

Rong Li, Jie Qiao, Ricardo Azziz, 2018, Fertility and sterility.

Polycystic ovary syndrome phenotype does not have impact on oocyte morphology

D. Dewailly, C. Decanter, A. barbotin, 2022, Reproductive Biology and Endocrinology.

Toward a universal serum antimüllerian hormone threshold as a surrogate for polycystic ovarian morphology on ultrasound: the story is not over….

D. Dewailly, 2021, Fertility and sterility.

Anti-Müllerian hormone as a driving force of polycystic ovary syndrome, independently from insulin resistance.

D. Dewailly, A. barbotin, S. Catteau-jonard, 2021, Reproductive biomedicine online.

Counting follicles to define polycystic ovary morphology: should we change the way we do it?

D. Dewailly, 2021, Fertility and sterility.

Polycystic ovary syndrome

Richard S Legro, Didier Dewailly, T. Hickey, 2007, The Lancet.

Role of Anti-Müllerian Hormone in the Pathogenesis of Polycystic Ovary Syndrome

D. Dewailly, A. barbotin, S. Catteau-jonard, 2020, Frontiers in Endocrinology.

Anti-Müllerian Hormone (AMH) in Adults

D. Dewailly, S. Catteau-jonard, G. Robin, 2019, Encyclopedia of Endocrine Diseases.

Anti-müllerian hormone in the pathophysiology and diagnosis of polycystic ovarian syndrome

D. Dewailly, G. Robin, A. Dumont, 2018, Current opinion in endocrinology, diabetes, and obesity.

Comparative assessment of five serum antimüllerian hormone assays for the diagnosis of polycystic ovary syndrome.

A. Duhamel, D. Dewailly, S. Catteau-jonard, 2016, Fertility and sterility.

[Anti-Mullerian hormone: an ovarian hormone exerting hypothalamic feedback?].

V. Prévot, D. Dewailly, P. Giacobini, 2016, Medecine sciences : M/S.

Consensus of the French Endocrine Society on Female Hyperandrogenism Polycystic ovary syndrome (PCOS)

D. Dewailly, S. Hiéronimus, P. Mirakian, 2010 .

Increased anti-Müllerian hormone and decreased FSH levels in follicular fluid obtained in women with polycystic ovaries at the time of follicle puncture for in vitro fertilization.

D. Dewailly, C. Lefebvre, S. Catteau-jonard, 2010, Fertility and sterility.

The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest.

D. Dewailly, S. Jonard, 2004, Human reproduction update.

The ovarian markers of the FSH insufficiency in functional hypothalamic amenorrhoea.

D. Dewailly, P. Pigny, Y. Robert, 2005, Human reproduction.

Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome.

D. Dewailly, P. Pigny, Y. Robert, 2006, The Journal of clinical endocrinology and metabolism.

[Hyperandrogenism in women].

D. Dewailly, M. Peigné, G. Robin, 2013, Presse medicale.

21-Hydroxylase-deficient nonclassic adrenal hyperplasia is a progressive disorder: a multicenter study.

V. Rohmer, D. Pignatelli, R. Azziz, 2000, American journal of obstetrics and gynecology.

Experts’ opinion on inositols in treating polycystic ovary syndrome and non-insulin dependent diabetes mellitus: a further help for human reproduction and beyond

A. S. Laganà, M. Bizzarri, A. Stringaro, 2020, Expert opinion on drug metabolism & toxicology.

Anti-Müllerian hormone serum level and other markers associated with pregnancy outcome in oocyte donation

D. Dewailly, S. Catteau-jonard, G. Robin, 2016, Reproductive Biology and Endocrinology.

AMH assessment five or more years after an initially low AMH level.

D. Dewailly, S. Catteau-jonard, G. Robin, 2020, European journal of obstetrics, gynecology, and reproductive biology.

Follicle Excess and Abnormalities in Women with PCOS: Pathophysiology, Assessment and Clinical Role

D. Dewailly, A. Dumont, P. Plouvier, 2018 .

Could myo-inositol soft gel capsules outperform clomiphene in inducing ovulation? Results of a pilot study.

D. Dewailly, M. Peigné, S. Catteau-jonard, 2017, European review for medical and pharmacological sciences.

Next Generation Sequencing Should Be Proposed to Every Woman With “Idiopathic” Primary Ovarian Insufficiency

P. Touraine, C. Dodé, S. Christin‐Maitre, 2021, Journal of the Endocrine Society.

Metabolic syndrome in young women with the polycystic ovary syndrome: revisiting the threshold for an abnormally decreased high‐density lipoprotein cholesterol serum level

D. Dewailly, S. Catteau-jonard, C. Gallo, 2010, BJOG : an international journal of obstetrics and gynaecology.

How actual is the dietary treatment in overweighting patients with polycystic ovary syndrome?

D. Dewailly, C. Cortet-Rudelli, 1998, Journal of endocrinological investigation.

Choice of stimulation in polycystic ovarian syndrome: the influence of obesity.

J. Bringer, P. Pujol, D. Dewailly, 1997, Human reproduction.

Serum α-Inhibin Levels in Polycystic Ovary Syndrome: Relationship to the Serum Androstenedione Level1

A. Duhamel, D. Dewailly, P. Pigny, 1997 .

Cushing’s Syndrome, Acromegaly, and Androgen Excess

D. Dewailly, A. Reyss, 2006 .

Revisiting the serum level of anti-Müllerian hormone in patients with functional hypothalamic anovulation.

D. Dewailly, S. Catteau-jonard, G. Robin, 2021, Human reproduction.

Polycystic ovaries at ultrasound: normal variant or silent polycystic ovary syndrome?

D. Dewailly, S. Catteau-jonard, G. Robin, 2012, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

Carriers of 21-hydroxylase deficiency are not at increased risk for hyperandrogenism.

R. Azziz, E. Knochenhauer, D. Dewailly, 1997, The Journal of clinical endocrinology and metabolism.

Markers of Abdominal Adipose Tissue in Women: Relationship to Ovarian Function

D. Dewailly, C. Cortet-Rudelli, D. Deroubaix-Allard, 1998, Trends in Endocrinology & Metabolism.

[Biomarkers in endocrinology].

J. Wemeau, D. Dewailly, M. D'herbomez, 2014, Presse medicale.

Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency revisited: an update with a special focus on adolescent and adult women.

F. Keleştimur, H. Escobar-Morreale, R. Azziz, 2017, Human reproduction update.

Inositols in Polycystic Ovary Syndrome: An Overview on the Advances

A. S. Laganà, Z. Kamenov, E. Diamanti-Kandarakis, 2020, Trends in Endocrinology & Metabolism.

SEMA3A, a Gene Involved in Axonal Pathfinding, Is Mutated in Patients with Kallmann Syndrome

J. Hardelin, Jacques Young, C. Cruaud, 2012, PLoS genetics.

Somatostatin receptors, adenylate cyclase activity, and growth hormone (GH) response to octreotide in GH-secreting adenomas.

P. Chanson, J. Bertherat, F. Peillon, 1993, The Journal of clinical endocrinology and metabolism.

Basal and dynamic relationships between serum anti-Müllerian hormone and gonadotropins in patients with functional hypothalamic amenorrhea, with or without polycystic ovarian morphology

R. Marculescu, D. Dewailly, J. Marschalek, 2022, Reproductive Biology and Endocrinology.

Mutations and sequence variants in GDF9 and BMP15 in patients with premature ovarian failure.

R. Frydman, R. Veitia, M. Fellous, 2006, European journal of endocrinology.

The prevalence of CHD7 missense versus truncating mutations is higher in patients with Kallmann syndrome than in typical CHARGE patients.

J. Hardelin, Jacques Young, D. Lacombe, 2014, The Journal of clinical endocrinology and metabolism.

Polycystic ovary syndrome phenotype does not have impact on oocyte morphology

D. Dewailly, C. Decanter, A. barbotin, 2021, Reproductive Biology and Endocrinology.

Clinical Outcome, Hormonal Status, Gonadotrope Axis, and Testicular Function in 219 Adult Men Born With Classic 21-Hydroxylase Deficiency. A French National Survey.

Jacques Young, J. Bertherat, P. Caron, 2015, The Journal of clinical endocrinology and metabolism.

Clinical review 56: Nonclassic adrenal hyperplasia: current concepts.

R. Azziz, D. Dewailly, D. Owerbach, 1994, The Journal of clinical endocrinology and metabolism.

[Ovulation induction by pulsatile GnRH therapy in 2014: literature review and synthesis of current practice].

D. Dewailly, M. Peigné, S. Catteau-jonard, 2014, Gynecologie, obstetrique & fertilite.

Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome†‡

L. Redman, B. Mol, J. Qiao, 2018, Human reproduction.

Recurrent maternal virilization during pregnancy in patients with PCOS: two clinical cases

D. Dewailly, S. Catteau-jonard, A. Bruyneel, 2018, Reproductive Biology and Endocrinology.

Anti-Mullerian hormone, its receptor, FSH receptor, and androgen receptor genes are overexpressed by granulosa cells from stimulated follicles in women with polycystic ovary syndrome.

D. Dewailly, S. Catteau-jonard, S. P. Jamin, 2008, The Journal of clinical endocrinology and metabolism.

Pituitary microadenomas: experience with Gd-DOTA-enhanced MR imaging at 0.5 Telsa.

P. Fossati, J. Pruvo, X. Leclerc, 1994, European journal of radiology.

Reproductive outcome of women with 21-hydroxylase-deficient nonclassic adrenal hyperplasia.

V. Rohmer, F. Keleştimur, D. Pignatelli, 2007, The Journal of clinical endocrinology and metabolism.

The human chorionic gonadotropin test is more powerful than the gonadotropin-releasing hormone agonist test to discriminate male isolated hypogonadotropic hypogonadism from constitutional delayed puberty.

D. Dewailly, C. Cortet-Rudelli, B. Soudan, 2003, European journal of endocrinology.

Changes in serum anti-mullerian hormone level during low-dose recombinant follicular-stimulating hormone therapy for anovulation in polycystic ovary syndrome.

D. Dewailly, C. Decanter, S. Catteau-jonard, 2007, The Journal of clinical endocrinology and metabolism.

Low vitamin D3 and high anti-Müllerian hormone serum levels in the polycystic ovary syndrome (PCOS): Is there a link?

D. Dewailly, P. Giacobini, S. Catteau-jonard, 2016, Annales d'endocrinologie.

Inositols: From Established Knowledge to Novel Approaches

N. Greene, A. Copp, M. Bizzarri, 2021, International journal of molecular sciences.

A multicenter study of women with nonclassical congenital adrenal hyperplasia: relationship between genotype and phenotype.

R. Azziz, E. Knochenhauer, D. Dewailly, 2000, Molecular genetics and metabolism.

Bone Ultrasonometry and Turnover Markers in Primary Hyperparathyroidism

X. Marchandise, D. Dewailly, B. Cortet, 2000, Calcified Tissue International.

Use of the serum anti-Müllerian hormone assay as a surrogate for polycystic ovarian morphology: impact on diagnosis and phenotypic classification of polycystic ovary syndrome

D. Dewailly, S. Catteau-jonard, G. Robin, 2017, Human reproduction.

Effect of obesity and its related metabolic factors on serum anti-Müllerian hormone concentrations in women with and without polycystic ovaries.

D. Dewailly, P. Pigny, T. Lefebvre, 2017, Reproductive biomedicine online.

[Focus on intrauterine contraception in 15 questions and answers].

D. Dewailly, G. Robin, B. Letombe, 2012, Gynecologie, obstetrique & fertilite.

Clinical and biological phenotypes in late-onset 21-hydroxylase deficiency.

P. Fossati, J. Lefebvre, D. Dewailly, 1986, The Journal of clinical endocrinology and metabolism.

[Transvaginal hydrolaparoscopy for infertility investigation: a retrospective study, about 262 patients].

D. Dewailly, C. Rubod, M. Leroy, 2014, Gynecologie, obstetrique & fertilite.

Dopamine-secreting pheochromocytoma: an unrecognized entity? Classification of pheochromocytomas according to their type of secretion.

P. Fossati, C. Proye, J. Lefebvre, 1986, Surgery.

Antibody method for measurement of dihydrotestosterone receptors in cultured human skin fibroblasts.

C. Migeon, D. Dewailly, M. Maes, 1979, The Journal of laboratory and clinical medicine.

Screening heterozygotes for 21-hydroxylase deficiency among hirsute women: lack of utility of the adrenocorticotropin hormone test.

P. Fossati, D. Dewailly, M. Vantyghem, 1988, Fertility and sterility.

Ectopic hyperprolactinaemia in a woman with a mesocolic perivascular epithelioid cell tumor ("PEComa").

E. Leteurtre, X. Leroy, B. Neraud, 2008, Annales d'endocrinologie.

Prospective assessment of follicular growth and the oocyte cohort after ovarian stimulation for fertility preservation in 90 cancer patients versus 180 matched controls.

P. Devos, D. Dewailly, C. Decanter, 2018, Reproductive biomedicine online.

Anti-Müllerian hormone follow-up in young women treated by chemotherapy for lymphoma: preliminary results.

D. Dewailly, C. Decanter, F. Morschhauser, 2010, Reproductive biomedicine online.

Androgen excess disorders in women

R. Azziz, D. Dewailly, J. Nestler, 2007 .

Ultrasound assessment of the polycystic ovary: international consensus definitions.

Didier Dewailly, Seang Tan, J. Laven, 2003, Human reproduction update.

Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries.

A. Duhamel, D. Dewailly, M. Leroy, 2011, Human reproduction.

Prospective study into the value of the automated Elecsys antimüllerian hormone assay for the assessment of the ovarian growing follicle pool.

L. Nardo, E. Anckaert, J. Smitz, 2015, Fertility and sterility.

[Contribution of ovarian and uterine color Doppler in medically assisted reproduction techniques (ART)].

D. Dewailly, M. Leroy, C. Lefebvre, 2002, Gynecologie, obstetrique & fertilite.

Elevated prenatal anti-Müllerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood

T. Piltonen, V. Prévot, A. Loyens, 2018, Nature Medicine.

The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report.

R. Norman, H. Escobar-Morreale, E. Diamanti-Kandarakis, 2009, Fertility and sterility.

Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline.

R. Norman, H. Escobar-Morreale, E. Diamanti-Kandarakis, 2006, The Journal of clinical endocrinology and metabolism.

[Ovarian hyperstimulation syndrome after stimulation with highly purified hMGfor in vitro fertilization: Observational study SHOview].

A. Duhamel, P. Barrière, D. Dewailly, 2017, Gynecologie, obstetrique, fertilite & senologie.

The polycystic ovary syndrome. A position statement from the European Society of Endocrinology

G. Conway, E. Diamanti-Kandarakis, D. Dewailly, 2015 .

The polycystic ovary syndrome: a position statement from the European Society of Endocrinology.

F. Keleştimur, D. Pignatelli, H. Escobar-Morreale, 2014, European journal of endocrinology.

The polycystic ovary syndrome: a position statement from the European Society of

F. Keleştimur, D. Pignatelli, G. Conway, 2014 .

The serum inhibin B concentration and reference ranges in normozoospermia.

A. Duhamel, D. Dewailly, J. Rigot, 2015, European journal of endocrinology.

Pregnancy after intracytoplasmic sperm injection following extended sperm preparation and hormone therapy in an azoospermic man with maturation arrest and microlithiasis: a case report and literature review

D. Dewailly, J. Rigot, M. Leroy, 2017, Andrologia.

[Cryptorchidism: from physiopathology to infertility].

P. Colin, D. Dewailly, J. Rigot, 2010, Gynecologie, obstetrique & fertilite.

Polycystic ovary syndrome (PCOS).

D. Dewailly, S. Hiéronimus, D Dewailly, 2010, Annales d'endocrinologie.

Extreme spermatogenesis failure: andrological phenotype and intracytoplasmic sperm injection outcomes

D. Dewailly, J. Rigot, V. Mitchell, 2017, Andrology.

[Why and how to assess hypospermia?].

L. Lemaitre, D. Dewailly, J. Rigot, 2008, Gynecologie, obstetrique & fertilite.

In cases of familial primary ovarian insufficiency and disorders of gonadal development, consider NR5A1/SF-1 sequence variants.

P. Philibert, D. Dewailly, Y. Morel, 2019, Reproductive biomedicine online.

Molecular cytogenetic studies of Xq critical regions in premature ovarian failure patients.

R. Frydman, N. Bourcigaux, G. Tachdjian, 2006, Human reproduction.

Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest.

D. Dewailly, C. Decanter, P. Pigny, 2003, The Journal of clinical endocrinology and metabolism.

Adrenocortical hyperresponsivity to adrenocorticotropic hormone: a mechanism favoring the normal production of cortisol in 21-hydroxylase-deficient nonclassic adrenal hyperplasia.

R. Azziz, E. Knochenhauer, D. Dewailly, 2000, Fertility and sterility.

[Glycoprotein hormones, glycosylation and biological activity].

D. Dewailly, P. Pigny, A. Boersma, 1992, Annales de biologie clinique.

A short history of PCOS: from the discovery of the disease to recent guidelines

Jacques Young, D. Dewailly, G. Robin, 2019 .

Effects of the dopamine agonist CV 205-502 in human prolactinomas resistant to bromocriptine.

D. Dewailly, I. Morange, T. Brue, 1992, The Journal of clinical endocrinology and metabolism.

DEBATE: AMH as the Primary Marker for Fertility.

J. Laven, D. Dewailly, 2019, European journal of endocrinology.

Spontaneous pregnancy in a patient who was homozygous for the Q106R mutation in the gonadotropin-releasing hormone receptor gene.

D. Dewailly, C. Decanter, A. Boucher, 2002, Fertility and sterility.

Identification of new biomarkers of human endometrial receptivity in the natural cycle.

J. de Vos, D. Dewailly, S. Hamamah, 2008, Human reproduction.

Serum FSH level is lower in dysovulating than in ovulating non-PCOS obese women, independently of body mass index.

D. Dewailly, S. Catteau-jonard, G. Robin, 2019, Annales d'endocrinologie.

Pathophysiology of polycystic ovary syndrome: the role of hyperandrogenism.

D. Dewailly, S. Catteau-jonard, 2013, Frontiers of hormone research.

Array comparative genomic hybridization profiling analysis reveals deoxyribonucleic acid copy number variations associated with premature ovarian failure.

R. Frydman, B. Donadille, N. Bourcigaux, 2009, The Journal of clinical endocrinology and metabolism.

Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society.

F. Keleştimur, R. Norman, H. Escobar-Morreale, 2012, Human reproduction update.

In cases of familial primary ovarian insufficiency and disorders of gonadal development, consider NR5A1/SF-1 sequence variants.

P. Philibert, D. Dewailly, Y. Morel, 2019, Reproductive biomedicine online.

Epigenetics suggests new perspectives for the treatment of polycystic ovary syndrome: Transgenerational effect of fetal exposure to Antimüllerian Hormone

D. Dewailly, M. Pugeat, 2022, Annales d'Endocrinologie.

Toward a better follow-up of ovarian recovery in young women after chemotherapy with a hypersensitive antimüllerian hormone assay.

D. Dewailly, C. Decanter, F. Morschhauser, 2014, Fertility and sterility.

Comparison between pulsatile GnRH therapy and gonadotropins for ovulation induction in women with both functional hypothalamic amenorrhea and polycystic ovarian morphology

D. Dewailly, S. Catteau-jonard, G. Robin, 2016, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Does polycystic ovarian morphology influence the response to treatment with pulsatile GnRH in functional hypothalamic amenorrhea?

D. Dewailly, S. Catteau-jonard, G. Robin, 2016, Reproductive Biology and Endocrinology.

The excess in 2-5 mm follicles seen at ovarian ultrasonography is tightly associated to the follicular arrest of the polycystic ovary syndrome.

D. Dewailly, S. Catteau-jonard, P. Pigny, 2007, Human reproduction.

Ultrasound examination of polycystic ovaries: is it worth counting the follicles?

D. Dewailly, C. Decanter, P. Pigny, 2003, Human reproduction.

Serum levels of inhibins are differentially altered in patients with polycystic ovary syndrome: effects of being overweight and relevance to hyperandrogenism.

A. Duhamel, D. Dewailly, C. Decanter, 2000, Fertility and sterility.

Ultrasound assessment of ovarian stroma hypertrophy in hyperandrogenism and ovulation disorders: visual analysis versus computerized quantification.

L. Lemaitre, D. Dewailly, Y. Robert, 1995, Fertility and sterility.

Feminizing adreno-cortical carcinomas in male adults. A dire prognosis. Three cases in a series of 801 adrenalectomies and review of the literature.

C. Proye, M. Decoulx, D. Dewailly, 2006, Annales d'endocrinologie.

Puberty and polycystic ovarian syndrome: The insulin/insulin‐like growth factor I hypothesis

D. Dewailly, F. Nobels, 1993, Fertility and sterility.

Puberty and polycystic ovarian syndrome: the insulin/insulin-like growth factor I hypothesis.

D. Dewailly, E. Wallach, F. Nobels, 1992 .

11beta-hydroxyandrostenedione and delta5-androstenediol as markers of adrenal androgen production in patients with 21-hydroxylase-deficient nonclassic adrenal hyperplasia.

R. Azziz, E. Knochenhauer, D. Dewailly, 1999, Fertility and sterility.

Hyperandrogenism in adolescent girls.

D. Dewailly, C. Cortet-Rudelli, 2004, Endocrine development.

Assessment of theca cell function prior to controlled ovarian stimulation: the predictive value of serum basal/stimulated steroid levels.

D. Dewailly, C. Coussieu, I. Cédrin-Durnerin, 2010, Human reproduction.

Immunohistochemical detection of glycoprotein hormone alpha subunit in somatoprolactinic and pure somatotroph adenomas

D. Dewailly, M. Vantyghem, C. Bauters, 1998, Journal of endocrinological investigation.

Factors associated with pregnancy after in vitro fertilization in infertile patients with posterior deep pelvic endometriosis: A retrospective study.

D. Dewailly, C. Rubod, J. Lepage, 2019, Journal of gynecology obstetrics and human reproduction.

Obesity and serum luteinizing hormone level have an independent and opposite effect on the serum inhibin B level in patients with polycystic ovary syndrome.

D. Dewailly, M. Leroy, C. Decanter, 2002, Fertility and sterility.

Anti-Müllerian Hormone in PCOS: A Review Informing International Guidelines

H. Teede, R. Norman, J. Laven, 2019, Trends in Endocrinology & Metabolism.

Profile and outcome of pure androgen-secreting adrenal tumors in women: experience of 21 cases.

E. Leteurtre, S. Aubert, C. Proye, 2004, Surgery.

A long-acting repeatable form of bromocriptine as long-term treatment of prolactin-secreting macroadenomas: a multicenter study.

I. Lancranjan, J. Louvet, P. Roger, 1992, Fertility and sterility.

Slow release lanreotide treatment in acromegalic patients previously normalized by octreotide.

P. Chanson, D. Dewailly, I. Morange, 1994, The Journal of clinical endocrinology and metabolism.

Total prolactin binding sites in human breast cancer biopsies

P. Kelly, J. Bonneterre, D. Dewailly, 2005, Breast Cancer Research and Treatment.

MRI protocol technique in the optimal therapeutic strategy of non-functioning pituitary adenomas.

J. Pruvo, G. Soto-Ares, R. Assaker, 2002, European journal of endocrinology.

[Impact of end-stage renal disease and kidney transplantation on the reproductive system].

F. Provôt, D. Dewailly, M. Peigné, 2015, Gynecologie, obstetrique & fertilite.

Medical treatment of hyperprolactinemia.

P. Fossati, A. Lemaire, D. Dewailly, 1985, Hormone Research.

The Nonclassic Adrenal Hyperplasias

R. Azziz, D. Dewailly, 2006 .

Loss of LH-induced down-regulation of anti-Müllerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome.

R. Fanchin, J. Taieb, D. Dewailly, 2013, Human reproduction.

Non-classic cytochrome P450 oxidoreductase deficiency strongly linked with menstrual cycle disorders and female infertility as primary manifestations.

Jacques Young, D. Dewailly, N. Pitteloud, 2020, Human reproduction.

[Physiopathological link between polycystic ovary syndrome and hyperprolactinemia: myth or reality?].

Jacques Young, D. Dewailly, S. Catteau-jonard, 2011, Gynecologie, obstetrique & fertilite.

Programming in vitro fertilization retrievals during working days after a gonadotropin-releasing hormone antagonist protocol with estrogen pretreatment: does the length of exposure to estradiol impact on controlled ovarian hyperstimulation outcomes?

D. Dewailly, G. Priou, D. Colleu, 2011, Fertility and sterility.

The Psychosocial Impact of Polycystic Ovary Syndrome

D. Dewailly, M. Peigné, V. Simon, 2023, Reproductive Medicine.

[Delayed puberty with extreme uterine hypotrophy: do not conclude too early to the absence of the uterus].

D. Dewailly, E. Yollin, C. Cortet-Rudelli, 2007, Gynécologie Obstétrique & Fertilité.

Discordance between serum anti-Müllerian hormone concentrations and antral follicle counts: not only technical issues

D. Dewailly, N. Stojanovic, M. Alebić, 2018, Human reproduction.

The phenotypic diversity in per-follicle anti-Müllerian hormone production in polycystic ovary syndrome.

A. Duhamel, D. Dewailly, N. Stojanovic, 2015, Human reproduction.

Using cluster analysis to identify a homogeneous subpopulation of women with polycystic ovarian morphology in a population of non-hyperandrogenic women with regular menstrual cycles.

A. Duhamel, D. Dewailly, N. Stojanovic, 2014, Human reproduction.

Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society.

R. Norman, H. Escobar-Morreale, J. Laven, 2014, Human reproduction update.

Weekly intramuscular progesterone for luteal phase support in women receiving oocyte donation is associated with a decreased miscarriage rate.

É. Drumez, D. Dewailly, S. Catteau-jonard, 2019, Reproductive biomedicine online.

Long term treatment with the somatostatin analog SMS 201-995 in a patient with a thyrotropin- and growth hormone-secreting pituitary adenoma.

M. Decoulx, J. Wemeau, D. Dewailly, 1988, The Journal of clinical endocrinology and metabolism.

Polycystic ovarian disease: contribution of vaginal endosonography and reassessment of ultrasonic diagnosis.

P. Fossati, L. Lemaitre, D. Dewailly, 1991, Fertility and sterility.

Spontaneous Hemoperitoneum during Pregnancy: A Diagnosis Pitfall

G. Piessen, D. Dewailly, M. Leroy, 2011, The American surgeon.

Which morphological investigations and how to interpret them to make the diagnosis of PCOS?

D. Dewailly, S. Catteau-jonard, E. Poncelet, 2010, Annales d'endocrinologie.

Polycystic Ovary Syndrome: Imaging polycystic ovaries

D. Dewailly, Y. Robert, S. Jonard, 2007 .

Revisiting the ovarian volume as a diagnostic criterion for polycystic ovaries.

Didier Dewailly, D. Dewailly, Sophie Jonard, 2005, Human reproduction.

Revisiting the ovarian volume as a criterion for the diagnosis of polycystic ovaries

D. Dewailly, Y. Robert, S. Jonard, 2004 .

Ovarian stromal hypertrophy in hyperandrogenic women.

P. Fossati, L. Lemaitre, D. Dewailly, 1995, Clinical endocrinology.

[Revelation of a polymicrocystic ovary syndrome after one month's treatment by pulsatile GnRH in a patient presenting with functional hypothalamic amenorrhea].

D. Dewailly, A. Reyss, C. Demerle, 2003, Gynecologie, obstetrique & fertilite.

Serum inhibin B during controlled ovarian hyperstimulation: an additional criterion for deciding whether to proceed with egg retrieval.

D. Dewailly, M. Leroy, C. Decanter, 2009, Fertility and sterility.

Nonclassic 21-hydroxylase deficiency.

D. Dewailly, 2002, Seminars in reproductive medicine.

Reconciling the definitions of polycystic ovary syndrome: the ovarian follicle number and serum anti-Müllerian hormone concentrations aggregate with the markers of hyperandrogenism.

A. Duhamel, D. Dewailly, C. Decanter, 2010, The Journal of clinical endocrinology and metabolism.

Follow-up study of two sisters with type A syndrome of severe insulin resistance gives a new insight into PCOS pathogenesis in relation to puberty and pregnancy outcome: a case report.

A. Vambergue, C. Lautier, F. Grigorescu, 2006, Human reproduction.

LH/hCGR gene expression in human cumulus cells is linked to the expression of the extracellular matrix modifying gene TNFAIP6 and to serum estradiol levels on day of hCG administration.

J. de Vos, S. Assou, D. Dewailly, 2009, Human reproduction.

Changes in circulating forms of anti-Muüllerian hormone and androgens in women with and without PCOS: a systematic longitudinal study throughout pregnancy

D. Dewailly, P. Giacobini, M. Peigné, 2023, Human reproduction.

Quantitative Ultrasound of Bone and Markers of Bone Turnover in Cushing’s Syndrome

X. Marchandise, M. Decoulx, J. Wemeau, 2001, Osteoporosis International.

MRI atlas of the human hypothalamus

Pierre Besson, Serge Blond, Marc Baroncini, 2012, NeuroImage.

Role of Anti-Müllerian Hormone in pathophysiology, diagnosis and treatment of Polycystic Ovary Syndrome: a review

Agathe Dumont, Didier Dewailly, Sophie Catteau-Jonard, 2015, Reproductive Biology and Endocrinology.

The role of serum anti-Müllerian hormone (AMH) in the hormonal diagnosis of polycystic ovary syndrome

D. Dewailly, E. Piccione, L. Casadei, 2013, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Breakthroughs in the Use of Inositols for Assisted Reproductive Treatment (ART)

N. Greene, A. Copp, M. Bizzarri, 2020, Trends in Endocrinology & Metabolism.

Anti-Müllerian hormone concentrations and parity in fertile women: the model of oocyte donors.

D. Dewailly, S. Catteau-jonard, G. Robin, 2017, Reproductive biomedicine online.

[Evaluation of the ovarian reserve].

P. Barrière, D. Dewailly, S. Catteau-jonard, 2010, Journal de gynecologie, obstetrique et biologie de la reproduction.

[Anti-Mullerian hormone and polycystic ovary syndrome].

D. Dewailly, S. Catteau-jonard, 2011, Gynecologie, obstetrique & fertilite.

Polycystic Ovary Syndrome Phenotype D Versus Functional Hypothalamic Amenorrhea With Polycystic Ovarian Morphology: A Retrospective Study About a Frequent Differential Diagnosis

R. Seemann, D. Dewailly, I. Holzer, 2022, Frontiers in Endocrinology.

Definition of polycystic ovary syndrome

D. Dewailly, 2000, Human fertility.

Age‐stratified thresholds of anti‐Müllerian hormone improve prediction of polycystic ovary syndrome over a population‐based threshold

D. Dewailly, 2017, Clinical endocrinology.

Polycystic Ovary-Like Abnormalities (PCO-L) in women with functional hypothalamic amenorrhea.

A. Duhamel, D. Dewailly, S. Catteau-jonard, 2012, The Journal of clinical endocrinology and metabolism.

Hyperandrogenism in adolescent girls.

D. Dewailly, S. Catteau-jonard, C. Cortet-Rudelli, 2012, Endocrine Development.

The numbers of 2– 5 and 6–9 mm ovarian follicles are inversely correlated in both normal women and in polycystic ovary syndrome patients: what is the missing link?

D. Dewailly, M. Peigné, S. Catteau-jonard, 2018, Human reproduction.

Resistance to somatostatin (SRIH) analog therapy in acromegaly. Re-evaluation of the correlation between the SRIH receptor status of the pituitary tumor and the in vivo inhibition of GH secretion in response to SRIH analog.

P. Chanson, J. Bertherat, J. Timsit, 1992, Hormone research.

Sex steroid hormones-related structural plasticity in the human hypothalamus

Jean-Pierre Pruvo, Marc Baroncini, Patrice Jissendi, 2010, NeuroImage.

Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society

F. Keleştimur, R. Norman, H. Escobar-Morreale, 2012 .

A case-control study about markers of stress in normal-/overweight women with polycystic ovary syndrome and in controls

C. Schneeberger, R. Marculescu, D. Dewailly, 2023, Frontiers in Endocrinology.

How to Choose the Optimal Starting Dose of Clomiphene Citrate (50 or 100 mg per Day) for a First Cycle of Ovulation Induction in Anovulatory PCOS Women?

D. Dewailly, C. Decanter, S. Catteau-jonard, 2023, Journal of clinical medicine.

Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome

L. Redman, J. Qiao, L. Moran, 2018, Clinical endocrinology.

Stress and polycystic ovarian morphology in functional hypothalamic amenorrhea: a retrospective cohort study

R. Marculescu, J. Parry, D. Dewailly, 2023, Reproductive Biology and Endocrinology.

Serum LH levels are associated to serum insulin and Anti‐Müllerian hormone levels in women with both functional hypothalamic amenorrhoea and polycystic ovarian morphology

D. Dewailly, S. Catteau-jonard, G. Robin, 2023, Clinical endocrinology.

[Treatment of pulmonary lymphangioleiomyomatosis using a GnRH agonist].

M. Copin, B. Wallaert, A. Tonnel, 1996, Revue des maladies respiratoires.

[Polycystic ovary syndrome: recent genetic contributions].

D. Dewailly, S. Jonard, 2002, Gynecologie, obstetrique & fertilite.

Polycystic ovary syndrome (PCOS).

D. Dewailly, S. Hiéronimus, J. hugues, 2010, Annales d'endocrinologie.

Outcome of Gastric Bypass Surgery on Patients with Polycystic Ovary Syndrome: A Review

G. Prager, D. Dewailly, J. Ott, 2023, Journal of clinical medicine.

Hypothalamic neuroglial plasticity is regulated by anti-Müllerian hormone and disrupted in polycystic ovary syndrome.

J. Pruvo, Renaud Lopes, S. Rasika, 2023, EBioMedicine.

Identification of new biomarkers of human endometrial receptivity in the natural cycle.

J. D. Vos, T. Rème, D. Dewailly, 2008, Human reproduction.

A gonadotroph adenoma with a high proportion of basic FSH isohormones by chromatofocusing.

D. Dewailly, N. Lahlou, P. Pigny, 1996, The Journal of clinical endocrinology and metabolism.

The physiology and clinical utility of anti-Mullerian hormone in women.

R. Fanchin, H. Mason, F. Broekmans, 2014, Human reproduction update.

Serum Anti-M??llerian Hormone as a Surrogate for Antral Follicle Count for Definition of the Polycystic Ovary Syndrome

D. Dewailly, P. Pigny, Y. Robert, 2006 .

The proportion of cleaved anti-Müllerian hormone is higher in serum but not follicular fluid of obese women independently of polycystic ovary syndrome.

É. Drumez, A. Loyens, D. Dewailly, 2020, Reproductive biomedicine online.

Is the suppressive effect of cyproterone acetate on serum anti-Müllerian-hormone levels in women with polycystic ovary syndrome stronger than under oral contraceptive pill?

D. Dewailly, M. Peigné, S. Catteau-jonard, 2016, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Non-equivalence of anti-Müllerian hormone automated assays—clinical implications for use as a companion diagnostic for individualised gonadotrophin dosing

R. Fanchin, S. Iliodromiti, R. Weiskirchen, 2017, Human Reproduction.

Editorial: PCOS: from infertility to pregnancy

D. Dewailly, S. Palomba, 2023, Frontiers in Endocrinology.

Human sex hormone-binding globulin variants associated with hyperandrogenism and ovarian dysfunction.

Patrice Cousin, Didier Dewailly, Kevin N Hogeveen, 2002, The Journal of clinical investigation.

Patient requests for improved diagnosis and information in polycystic ovary syndrome.

D. Dewailly, M. Pugeat, 2020, Annales d'endocrinologie.

Using serum anti-Müllerian hormone levels to predict the chance of live birth after spontaneous or assisted conception: a systematic review and meta-analysis.

D. Dewailly, M. Peigné, C. Sonigo, 2023, Human reproduction.

P-663 Serum anti-Müllerian hormone level to predict the chance of live birth after spontaneous or assisted conception: a systematic review and meta-analysis

D. Dewailly, M. Peigné, C. Sonigo, 2023, Human Reproduction.

Corticotropin releasing factor stimulation test in obssesive compulsive disorder

R. Beuscart, D. Dewailly, D. Bailly, 1994, Biological Psychiatry.

[Effects of nomegestrol acetate administered alone or with cutaneous 17 beta estradiol in inversed sequence on cycle quality and hot flashes in periomenopausal women].

D. Dewailly, M. Micheletti, M. Zartarian, 1998, Contraception, fertilite, sexualite.